In an industrial collaboration project, TU Wien has developed a medication that can alleviate or even completely eliminate the symptoms of celiac disease. It should be available as early as 2021.
Celiac disease is a fairly common disease, affecting one to two percent of the European population. It is expressed as a hypersensitivity to gluten, a protein found in cereals such as wheat, barley or rye.
Although efforts are already being made to treat celiac disease, the proposed drugs have an effect on the immune system. Possible side effects must therefore be examined very carefully. Although initial clinical studies are underway, they will not lead to a marketable product in the next few years.
For this reason, an entirely different approach has been pursued at TU Wien in collaboration with the industrial partner Sciotech Diagnostic Technologies GmbH. Instead of developing a drug that interferes with the immune system, TU Wien has created a simple medical product that directly attacks the gluten molecules to render them harmless. This makes the approval process much simpler, meaning that the product should be available in ordinary pharmacies as early as 2021.
Molecules like keys and locks
“Our bodies produce antibodies that fit intruding antigens precisely, like a key to a lock. This immune response makes these antigens harmless,” explains Professor Oliver Spadiut, head of the Integrated Bioprocess Development Research Group at TU Wien. “If a new antibody fragment is found and produced that docks to and blocks the invading gluten molecule without triggering the immune system, the symptoms of celiac disease can be suppressed.”
The aim of the research project was therefore to produce a complex of two such antibody fragments that envelop the gluten molecule at a molecular level, so that it can no longer have any further effects in the intestines.
To do this, certain bacteria have to be reprogrammed so that they produce exactly the desired antibody fragment. “The formation of such proteins in a bacterium is a highly complicated process,” explains Oliver Spadiut. “It can easily happen that the proteins are not folded exactly as we want.” Instead of the desired antibody fragments, so-called “inclusion bodies” are formed – small particles consisting of incorrectly folded proteins. A process therefore had to be developed to refold these inclusion bodies and to obtain the desired proteins from them.
Such processes, in which the folding of proteins is specifically altered, have not yet been studied in great detail and so they are not very efficient. “You have to precisely understand the chemical processes involved and intervene in a complicated way,” says Oliver Spadiut. “It has therefore taken a while, but we have now developed a process that can be easily reproduced, can be scaled up to industrial application and delivers a very good yield of the desired product”
In pharmacies soon
The project was supported by the industrial partner SCIOTEC Diagnostic Technologies GmbH, who will now bring the new medical product to the market. “It will be a preparation that celiac patients can take together with gluten-containing foods to alleviate coeliac symptoms,” explains Oliver Spadiut. “It remains to be seen whether the symptoms will disappear completely or will only be alleviated. The precise effects will probably vary from person to person.
Learn more: A new remedy for celiac disease
The Latest on: Celiac disease
via Google News
The Latest on: Celiac disease
- Researchers describe catatonia in Down syndromeon November 19, 2019 at 8:16 am
Inherited heart defects, thyroid cancer, celiac disease and developmental disabilities are common Down syndrome complications. Only recently has catatonia, a behavioral condition marked by new onset ...
- Could Avoiding or Limiting Certain Foods Help to Manage Psoriasis?on November 18, 2019 at 2:00 am
Based on research to date, the strongest evidence supports a gluten-free diet among patients with psoriasis who also have celiac disease (an autoimmune disease in which eating gluten can damage the ...
- Could Changing Your Diet Help With Managing Psoriasis?on November 15, 2019 at 12:34 pm
“Accordingly, the current recommendation is to reduce weight by reducing calories.” Psoriasis is associated with a higher risk of developing other autoimmune conditions like celiac disease. “While ...
- Cognizant and Beyond Celiac Team Up to Fund Research for a Celiac Disease Cureon November 14, 2019 at 4:40 pm
... Kenworthy have already raised over $6,000 for the cause by founding their Cognizant for Curing Celiac team with a mission to raise awareness and fund research for celiac disease, a genetic ...
- Dr. Stephen Frantz: Urges support for state bills banning glyphosateon November 14, 2019 at 9:39 am
Know anyone suffering from attention deficit disorder, Alzheimer’s disease, autism, cancer (non-Hodgkin’s lymphoma), celiac disease, colitis, heart disease, inflammatory bowel syndrome, kidney disease ...
- Single-cell TCR sequencing of gut intraepithelial γδ T cells reveals a vast and diverse repertoire in celiac diseaseon November 14, 2019 at 8:59 am
All prices are NET prices. VAT will be added later in the checkout.
- Celiac disease screening for family memberson November 14, 2019 at 7:35 am
Celiac disease is an immune reaction to eating gluten. A recent Mayo Clinic study found that this autoimmune disease tends to run in families. Researchers say screening family members of celiac ...
- 3 Cheers: Meet The Montgomery County Woman Who’s Trailblazing Moves Beyond Celiacon November 14, 2019 at 3:54 am
AMBLER, Pa. (CBS) — Alice Bast was diagnosed with celiac disease 26 years ago. With no treatment options or even proper food available to her, she decided to take it on herself. “I never envisioned ...
- Casey Wilson felt guilty after learning her son's mood swings were caused by celiac diseaseon November 12, 2019 at 7:22 am
Actress Casey Wilson is opening up about the shock of learning that her son's years of mysterious health problems were being caused by celiac disease. In a personal essay for The New York Times, ...
via Bing News